experimental group:high-dose dual therapy

2 trials

Sponsors

The First Affiliated Hospital of Nanchang University, Department of Gastroenterology,Army Medical Center of PLA (Daping Hospital)

Conditions

H. pylori infection eradicationHelicobacter pylori infection

Phase 4

A multicenter randomized controlled trial of optimised dual therapy and quadruple therapy containing metronidazole bismuth in newly treated patients with Helicobacter pylori

RecruitingChiCTR2000039096

Department of Gastroenterology,Army Medical Center of PLA (Daping Hospital)Helicobacter pylori infection

Start: 2020-10-28Updated: 2021-01-18

Unknown Phase

Randomized controlled trial for high-dose dual therapy versus bismuth quadruple therapy in the treatment of Helicobacter pylori in elderly patients

RecruitingChiCTR2000029679

The First Affiliated Hospital of Nanchang UniversityH. pylori infection eradication

Start: 2020-03-01Updated: 2020-02-10

Related Papers

Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy <i>versus</i> bismuth-containing quadruple therapy for <i>Helicobacter pylori</i> infection: a multicenter, randomized controlled clinical trial.

2022-12-265 citations